Partnership with Jiangxi Haoran Bio-pharma, China

[DAILY FARM = Reporter Seok Jun Lee] Highfly Co., Ltd. signed an exclusive supply contract with Jiangxi Haoran Bio-pharma Co., Ltd. for the raw material of 'Kallidinogenase'.

Kallidinogenase is an Active Pharmaceutical Ingredient (API) that effectively improves various symptoms caused by peripheral circulatory disorders and menopausal disorders.

Jiangxi Haoran Bio-pharma is a raw pharmaceutical development manufacturer using ingredients extracted from animal organs and exports them to more than ten countries, including Europe, Japan, Korea, and the United States.

Highfly and Jiangxi Haoran Bio-pharm agreed to cooperate each other under this agreement’s term. Kallidinogenase's KDMF registration was completed in 2022.

Reporter Seok Jun Lee (wiviwivi@dailypharm.com)